Protein-9 (CTRP9) levels associated with C1q tumor necrosis factor in obese preeclamptic, non-obese preeclamptic, obese and normal pregnant women

References

• American College of Obstetricians and Gynecologists. Hypertension in pregnancy; [cited 2015 Nov 23]. Available from:http://www.acog.org/Resources-And-Publications/Task-Force-and-Work-Group-Reports/Hypertension-in-Pregnancy.
   Google Scholar
• Warrington JP, George EM, Palei AC, et al. Recent advances in the understanding of the pathophysiology of preeclampsia. Hypertension. 2013;62(4):666–673.
   PubMed Web of Science ®Google Scholar
• Granger JP, Spradley FT, Bakrania BA. The endothelin system: a critical player in the pathophysiology of preeclampsia. Curr Hypertens Rep. 2018;20(4):32.
   PubMed Web of Science ®Google Scholar
• Matsubara K, Higaki T, Matsubara Y, et al. Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia. Int J Mol Sci. 2015;16(3):4600–4614.
   PubMed Web of Science ®Google Scholar
• Leiva A, Fuenzalida B, Barros E, et al. Nitric oxide is a central common metabolite in vascular dysfunction associated with diseases of human pregnancy. Curr Vasc Pharmacol. 2016;14(3):237–259.
   PubMed Web of Science ®Google Scholar
• Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997;272(2 Pt 2):R441–R463.
   PubMedGoogle Scholar
• Coroyannakis C, Khalil A. Management of hypertension in the obese pregnant patient. Curr Hypertens Rep. 2019;21(3):24.
   PubMed Web of Science ®Google Scholar
• Fuster JJ, Ouchi N, Gokce N, et al. Obesity-induced changes in adipose tissue microenvironment and their impact on cardiovascular disease. Circ Res. 2016;118(11):1786–1807.
   PubMed Web of Science ®Google Scholar
• García RG, Celedón J, Sierra-Laguado J, et al. Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens. 2007;20(1):98–103.
   PubMed Web of Science ®Google Scholar
• Spradley FT, Palei AC, Granger JP. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. Am J Physiol Regul Integr Comp Physiol. 2015;309(11):R1326–R1343.
   PubMed Web of Science ®Google Scholar
• Atawia RT, Bunch KL, Toque HA, et al. Mechanisms of obesity-induced metabolic and vascular dysfunctions. Front Biosci. 2019;24:890–934.
   Web of Science ®Google Scholar
• Spradley FT. Metabolic abnormalities and obesity’s impact on the risk for developing preeclampsia. Am J Physiol Regul Integr Comp Physiol. 2017;312(1):R5–R12.
   PubMed Web of Science ®Google Scholar
• Wong GW, Wang J, Hug C, et al. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA. 2004;101(28):10302–10307.
   PubMed Web of Science ®Google Scholar
• Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord. 2014;15(2):111–123.
   PubMed Web of Science ®Google Scholar
• Hwang YC, Woo Oh S, Park SW, et al. Association of serum C1q/TNF-related protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Int J Obes. 2014;38(9):1207–1212.
   Web of Science ®Google Scholar
• Zheng Q, Yuan Y, Yi W, et al. C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway. Arterioscler Thromb Vasc Biol. 2011;31(11):2616–2623.
   PubMed Web of Science ®Google Scholar
• Deng Y, Scherer PE. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci. 2010;1212:E1–E19.
   PubMed Web of Science ®Google Scholar
• Lopez-Jaramillo P, Barajas J, Rueda-Quijano SM, et al. Obesity and preeclampsia: common pathophysiological mechanisms. Front Physiol. 2018;9:1838.
   PubMed Web of Science ®Google Scholar
• Lau WB, Ohashi K, Wang Y, et al. Role of adipokines in cardiovascular disease. Circ J. 2017;81(7):920–928.
   PubMed Web of Science ®Google Scholar
• Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J. 2008;416(2):161–177.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Ohashi K, Shibata R, et al. Protective roles of adipocytokines and myokines in cardiovascular disease. Circ J. 2016;80(10):2073–2080.
   PubMed Web of Science ®Google Scholar
• Yuasa D, Ohashi K, Shibata R, et al. C1q/TNF-related protein-1 functions to protect against acute ischemic injury in the heart. Faseb J. 2016;30(3):1065–1075.
   PubMed Web of Science ®Google Scholar
• Yi W, Sun Y, Yuan Y, et al. C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation. 2012;125(25):3159–3169.
   PubMed Web of Science ®Google Scholar
• Kambara T, Shibata R, Ohashi K, et al. C1q/Tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-Dependent Mechanism. Mol Cell Biol. 2015;35(12):2173–2185.
   PubMed Web of Science ®Google Scholar
• Jung CH, Lee MJ, Kang YM, et al. C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells. Mol Cell Endocrinol. 2016;419:235–243.
   PubMed Web of Science ®Google Scholar
• Uemura Y, Shibata R, Ohashi K, et al. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. Faseb J. 2013;27(1):25–33.
   PubMed Web of Science ®Google Scholar
• Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, et al. Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin. Faseb J. 2009;23:41–258.
   Web of Science ®Google Scholar
• Fisslthaler B, Fleming I. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res. 2009;105(2):114–127.
   PubMed Web of Science ®Google Scholar
• Ouchi N, Kobayashi H, Kihara S, et al. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem. 2004;279(2):1304–1309.
   PubMed Web of Science ®Google Scholar
• Cheng KK, Lam KS, Wang Y, et al. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes. 2007;56(5):1387–1394.
   PubMed Web of Science ®Google Scholar
• Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278(45):45021–45026.
   PubMed Web of Science ®Google Scholar
• (a) Nakamura K, Fuster JJ, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014;63(4):250–259. (b) Sun H, Zhu X, Zhou Y. C1q/TNF-related protein-9 ameliorates Ox-LDL-induced endothelial dysfunction via PGC-1α/AMPK-mediated antioxidant enzyme Induction. Int J Mol Sci. 201726;18(6):1097.
   PubMed Web of Science ®Google Scholar
• Hendler I, Blackwell SC, Mehta SH, et al. The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia. Am J Obstet Gynecol. 2005;193(3):979–983.
   PubMed Web of Science ®Google Scholar
• Thagaard IN, Hedley PL, Holm JC, et al. Leptin and adiponectin as markers for preeclampsia in obese pregnant women, a cohort study. Pregnancy Hypertens. 2019;15:78–83. Jan
   PubMed Web of Science ®Google Scholar
• Acar D, Tayyar A, Yuksel A, et al. Increased maternal C1q/TNF-related protein-1 (CTRP1) serum levels in pregnancies with preeclampsia. Matern Fetal Neonatal Med. 2018;13:1–6.
   Google Scholar
• Rasouli N, Kern PA. Adipocytokines and the Metabolic Complications of Obesity. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S64–S73.
   PubMed Web of Science ®Google Scholar
• Jeyabalan A. Epidemiology of preeclampsia: Impact of obesity. Nutr Rev. 2013;71:S18–S25.
   PubMed Web of Science ®Google Scholar
• Derbyshire E. Can Anthropometric and body composition measurements during pregnancy be used to predict preeclampsia risk. CWHR. 2009;5(4):225–229.
   Google Scholar
• Liang X, Chen X, Li J, et al. Study on body composition and its correlation with obesity: a Cohort Study in 5121 Chinese Han participants. Medicine. 2018;97(21):e10722.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Bodnar LM, Patrick TE, et al. The Role of Obesity in Preeclampsia. Pregnancy Hypertens. 2011;1(1):6–123.
   PubMed Web of Science ®Google Scholar
• Adu-Gyamfi EA, Fondjo LA, Owiredu W, et al. The role of adiponectin in placentation and preeclampsia. Cell Biochem Funct. 2020;38(1):106–117.
   PubMed Web of Science ®Google Scholar
• Song Y, Gao J, Qu Y, et al. Serum levels of leptin, adiponectin and resistin in relation to clinical characteristics in normal pregnancy and preeclampsia. Clin Chim Acta. 2016;458:133–137.
   PubMed Web of Science ®Google Scholar